Objective and design: This post-marketing surveillance study collected data on the efficacy and tolerability of acarbose in patients ... fasting blood glucose by 32.4 mg/dL, and postprandial ...
Objective: The efficacy and tolerability of acarbose were examined in a postmarketing surveillance study of 27,803 patients with diabetes mellitus (26,044 were diagnosed as having type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback